NEOGENOMICS INC — Director's Dealing 2025

Feb 25, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2025-02-21

Reporting Person: Aunan Greg D (Chief Accounting Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-21	Stock Option (Right to Buy)	$11.86	A	31163	Acquired	2035-02-21	Common Stock (31163)	Direct
2025-02-21	Restricted Stock Unit	$0	A	18971	Acquired		Common Stock (18971)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14453	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$14.62	2030-05-01	Common Stock (28662)	28662	Direct
Stock Option (Right to Buy)	$13.96	2034-05-02	Common Stock (26978)	26978	Direct
Restricted Stock Unit	$0		Common Stock (16117)	16117	Direct

Footnotes

F1: On February 21, 2025, Mr. Aunan was granted 31,163 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F2: On February 21, 2025, Mr. Aunan was granted 18,971 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F3: Once vested, the shares of common stock are not subject to expiration.

F4: On May 1, 2023, Mr. Aunan was granted 28,662 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F5: On May 2, 2024, Mr. Aunan was granted 26,978 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F6: On May 2, 2024, Mr. Aunan was granted 16,117 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.